First-biopsy diagnostic rate in sinonasal malignant lymphoma: a single-center retrospective study of 24 cases
Background Sinonasal malignant lymphoma accounts for approximately 1% of head and neck malignancies, and necrosis often precludes diagnosis on a single biopsy.Aims/Objectives To determine the first-biopsy diagnostic rate by site of origin, histologic subtype, and biopsy method, and to describe the modifications made at repeat biopsy in non-diagnostic cases.Material and Methods We retrospectively reviewed 24 patients with sinonasal malignant lymphoma at a single university hospital (2014–2024; median age 68.5 years; 15 men, 9 women).Results Subtypes were diffuse large B-cell lymphoma (DLBCL; 12), extranodal NK/T-cell lymphoma (ENKL; 8), MALT lymphoma (2), and others (2); sites were the nasal cavity (12) and maxillary (6), ethmoid (5), and sphenoid (1) sinuses. The overall first-biopsy diagnostic rate was 70.8% (17/24): 75.0% for DLBCL (9/12) and ENKL (6/8), 83.3% (10/12) for the nasal cavity, and 58.3% (7/12) for the paranasal sinuses (p = 0.371). Five of seven non-diagnostic cases involved the paranasal sinuses, with only non-specific inflammation and necrosis.Conclusions and Significance Approximately 30% of cases were not diagnosed at the first biopsy, mostly paranasal sinus lesions. Although site differences were not significant, clinicians should anticipate repeat biopsy for paranasal sinus lesions; general anesthesia may be considered when adequate sampling is difficult under local anesthesia.
Authors
- Yumi Takemiya (ORCID: https://orcid.org/0009-0007-7984-2882)
- Kishiko Sunami
Institutions
- Tane General Hospital (JP)
- Osaka Metropolitan University (JP)
Publication Details
- Journal
- Acta Oto-Laryngologica
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1080/00016489.2026.2752842
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00